Cancer and Leukemia Group B

Known as: CALGB 
A national clinical research group - network of 29 university medical centers, over 185 community hospitals and more than almost 3000 physicians… (More)

Topic mentions per year

Topic mentions per year

1977-2017
020406019772017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
PURPOSE To determine the frequency of TET2 mutations, their associations with clinical and molecular characteristics and outcome… (More)
  • table 1
  • figure 1
  • table 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
PURPOSE The combination of gemcitabine plus bevacizumab produced a 21% response rate and a median survival of 8.8 months in a… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
PURPOSE To analyze the frequency and associations with prognostic markers and outcome of mutations in IDH genes encoding… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
PURPOSE Adjuvant chemotherapy for resected non-small-cell lung cancer (NSCLC) is now accepted on the basis of several randomized… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 3
Is this relevant?
Highly Cited
2006
Highly Cited
2006
PURPOSE To analyze the prognostic impact of mutated KIT (mutKIT) in core-binding factor acute myeloid leukemia (AML) with inv(16… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
PURPOSE The mechanisms responsible for prostate cancer androgen independence are diverse. Mutations of the androgen receptor (AR… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
We analyzed prospectively 1213 adults with de novo acute myeloid leukemia (AML) to ascertain the prognostic impact of cytogenetic… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
The Cancer and Leukemia Group B (CALGB) has been conducting a prospective cytogenetic companion study (CALGB 8461) to all CALGB… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
1998
Highly Cited
1998
BACKGROUND Both total dose and dose intensity of adjuvant chemotherapy are postulated to be important variables in the outcome… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
BACKGROUND For many years, high dose radiation therapy was the standard treatment for patients with locally or regionally… (More)
Is this relevant?